Amoéba S.A. (FRA:A1H)

Germany · Delayed Price · Currency is EUR

0.2820

-0.0045 (-1.57%)

Last updated: Oct 23, 2026, 9:05 AM CEST

Market Cap	20.15M -73.6%
Revenue (ttm)	758.45K +11.1%
Net Income	-11.80M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,190
Open	0.2820
Previous Close	0.2865
Day's Range	0.2820 - 0.2820
52-Week Range	0.2820 - 1.1180
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 24, 2026

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is headquartered in Chassieu, France. [Read more]

Industry Agricultural Inputs

Sector Materials

Founded 2010

Employees 23

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol A1H

Financial Performance

In 2025, Amoéba's revenue was 695,449, an increase of 15.60% compared to the previous year's 601,600. Losses were -8.30 million, 26.0% more than in 2024.

Financial Statements